Blood methylomic signatures of presymptomatic dementia in elderly subjects with type 2 diabetes mellitus

Neurobiology of Aging

Volumn 36, Issue 3, 2015, Pages 1600.e1-1600.e4

  Lunnon, Katie ^a   Smith, Rebecca G ^b   Cooper, Itzik ^c   Greenbaum, Lior ^c   Mill, Jonathan ^a,b   Beeri, Michal Schnaider ^c,d  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c SHEBA MEDICAL CENTER   (Israel)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease (AD); Biomarker; Blood; Dementia; DNA methylation; Epigenetics; Type 2 diabetes

Indexed keywords

DNA; GENOMIC DNA; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; COGNITION; CONTROLLED STUDY; CPG ISLAND; DEMENTIA; DISEASE ASSOCIATION; DNA METHYLATION; EARLY DIAGNOSIS; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PRIORITY JOURNAL; BLOOD; COMPLICATION; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; RISK; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; DEMENTIA; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LONGITUDINAL STUDIES; MALE; RISK; TIME FACTORS;

EID: 84923545445     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.12.023     Document Type: Article

References (26)

1. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 2004, 61:661-666.
2. Booij B.B., Lindahl T., Wetterberg P., Skaane N.V., Saebo S., Feten G., Rye P.D., Kristiansen L.I., Hagen N., Jensen M., Bardsen K., Winblad B., Sharma P., Lonneborg A. Agene expression pattern in blood for the early detection of Alzheimer's disease. J.Alzheimer's Dis. 2011, 23:109-119.
3. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimer's Dement. 2007, 3:186-191.
4. Chen Y.A., Lemire M., Choufani S., Butcher D.T., Grafodatskaya D., Zanke B.W., Gallinger S., Hudson T.J., Weksberg R. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 2013, 8:203-209.
5. Davis, S., Du, P., Bilke, S., Triche, J., Bootwalla, M. Methylumi: Handle Illumina Methylation Data 2012. R package version220.
6. De Jager P.L., Srivastava G., Lunnon K., Schalkwyk L.C., Yu L., Eaton M.L., Keenan B.T., Ernst J., McCabe C., Tang A., Raj T., Replogle J., Brodeur W., Gabriel S., Chai H., Younkin C., Younkin S.G., Zou F., Szyf M., Epstein C.B., Schneider J.A., Myers A.J., Ertekin-Taner N., Bernstein B.E., Meissner A., Chibnik L.B., Kellis M., Mill J., Bennett D.A. Alzheimer's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1 and other loci. Nat. Med. 2014, 17:1156-1163.
7. Fehlbaum-Beurdeley P., Sol O., Desire L., Touchon J., Dantoine T., Vercelletto M., Gabelle A., Jarrige A.C., Haddad R., Lemarie J.C., Zhou W., Hampel H., Einstein R., Vellas B. Validation of AclarusDx, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease. J.Alzheimer's Dis. 2012, 32:169-181.
8. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
9. Hye A., Lynham S., Thambisetty M., Causevic M., Campbell J., Byers H.L., Hooper C., Rijsdijk F., Tabrizi S.J., Banner S., Shaw C.E., Foy C., Poppe M., Archer N., Hamilton G., Powell J., Brown R.G., Sham P., Ward M., Lovestone S. Proteome-based plasma biomarkers for Alzheimer's disease. Brain 2006, 129(Pt 11):3042-3050.
10. Hye A., Riddoch-Contreras J., Baird A., Ashton N., Bazenet C., Leung R., Westman E., Simmons A., Dobson R., Sattlecker M., Lupton M.K., Lunnon K., Keohane A., Ward M., Pike I., Zucht H., Pepin D., Zheng W., Tunnicliffe A., Richardson J., Gauthie S., Soininen H., Kłoszewska I., Mecocci P., Tsolaki M., Vellas B., Lovestone S. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimer's Dement. 2014, 10:799-807.
11. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
12. Lunnon K., Sattlecker M., Furney S., Coppola G., Simmons A., Proitsi P., Lupton M.K., Lourdusamy A., Johnston C., Soininen H., Kloszewska I., Mecocci P., Tsolaki M., Vellas B., Geschwind D., Lovestone S., Dobson R., Hodges A. Ablood gene expression marker of early Alzheimer's disease. J.Alzheimer's Dis. 2013, 33:737-753.
13. Lunnon K., Smith R., Hannon E.J., De Jager P.L., Srivastava G., Volta M., Troakes C., Al-Sarraj S., Burrage J., Macdonald R., Condliffe D., Katsel P., Haroutunian V., Kaminsky Z., Joachim C., Powell J., Lovestone S., Bennett D.A., Schalkwyk L.C., Mill J. Cross-tissue methylomic profiling in Alzheimer's disease implicates a role for cortex-specific deregulation of ANK1 in neuropathology. Nat. Neurosci. 2014, 17:1156-1163.
14. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 2010, 28:495-501.
15. Mill J., Heijmans B.T. From promises to practical strategies in epigenetic epidemiology. Nat. Rev. Genet. 2013, 14:585-594.
16. O'Bryant S.E., Xiao G., Barber R., Reisch J., Doody R., Fairchild T., Adams P., Waring S., Diaz-Arrastia R. Aserum protein-based algorithm for the detection of Alzheimer disease. Arch. Neurol. 2010, 67:1077-1081.
17. O'Bryant S.E., Xiao G., Barber R., Reisch J., Hall J., Cullum C.M., Doody R., Fairchild T., Adams P., Wilhelmsen K., Diaz-Arrastia R. Ablood-based algorithm for the detection of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2011, 32:55-62.
18. Pidsley R., Wong C.C.Y., Volta M., Lunnon K., Mill J., Schalkwyk L.C. Adata-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 2013, 14:293.
19. Prince M., Bryce R., Albanese E., Wimo A., Ribeiro W., Ferri C.P. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer's Dement. 2013, 9:63-75 e2.
20. Ravona-Springer R., Heymann A., Schmeidler J., Guerrero-Berroa E., Sano M., Preiss R., Koifman K., Hoffman H., Levy A., Silverman J.M., Schnaider-Beeri M. Haptoglobin 1-1 genotype is associated with poorer cognitive functioning in the elderly with type 2 diabetes. Diabetes Care 2013, 36:3139-3145.
21. Ray S., Britschgi M., Herbert C., Takeda-Uchimura Y., Boxer A., Blennow K., Friedman L.F., Galasko D.R., Jutel M., Karydas A., Kaye J.A., Leszek J., Miller B.L., Minthon L., Quinn J.F., Rabinovici G.D., Robinson W.H., Sabbagh M.N., So Y.T., Sparks D.L., Tabaton M., Tinklenberg J., Yesavage J.A., Tibshirani R., Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 2007, 13:1359-1362.
22. R: A Language and Environment for Statistical Computing 2012, R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria.
23. Rye P.D., Booij B.B., Grave G., Lindahl T., Kristiansen L., Andersen H.M., Horndalsveen P.O., Nygaard H.A., Naik M., Hoprekstad D., Wetterberg P., Nilsson C., Aarsland D., Sharma P., Lonneborg A. Anovel blood test for the early detection of Alzheimer's disease. J.Alzheimer's Dis. 2011, 23:121-129.
24. Schnaider Beeri M., Goldbourt U., Silverman J.M., Noy S., Schmeidler J., Ravona-Springer R., Sverdlick A., Davidson M. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 2004, 63:1902-1907.
25. Stewart R., Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabetic Med. 1999, 16:93-112.
26. Thambisetty M., Hye A., Foy C., Daly E., Glover A., Cooper A., Simmons A., Murphy D., Lovestone S. Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease. J.Neurol. 2008, 255:1712-1720.